Schroder Ventures Life Sciences has raised $402 million (€344m) for
its biotechnology investment fund, providing a signal that venture
capital may at last be turning its head back in the direction of
METabolic EXplorer, a French biotechnology company specialising in
the development and production of new biological processes for the
manufacturing of chemicals and pharmaceuticals, has bolstered its
scientific team with the appointment...
Swiss chemicals group Lonza has said that a new small-scale
production plant at its Visp site will come on stream in July and
will boost its services in the area of exclusive manufacturing of
GEA Filtration has introduced a microfiltration plant for the
PharmaChem industries that, it claims, can perform studies on the
full range of filtration technologies using all types of filter
Cambrex has initiated a project aimed at constructing a new
facility to accommodate four cGMP-compliant suites dedicated to
cell therapy manufacturing. The company said the expansion would
increase its manufacturing capacity by 100...
Just over a year after acquiring the FSG business from Vivendi for
$360 million (€307m), Pall Corp has reported a healthy hike in
fiscal third-quarter sales and profits and once again raised its
earnings forecast for 2003.
Akzo Nobel's Diosynth unit has signed a multi-year contract to
manufacture and supply the active pharmaceutical ingredient for
Pfizer's growth hormone receptor antagonist Somavert. The value of
the agreement was not disclosed,...
AstraZeneca has opened a new multi-million dollar research facility
in Bangalore, India, which will focus principally on finding new
treatments for tuberculosis, a disease which is diagnosed in about
8 million people worldwide each...
Dutch firm Crucell has expanded its licensing agreement with US
drug major Merck & Co relating to PER.C6, the former's
proprietary cell technology platform used for the production of
The European Union's Employment, Social Policy, Health and Consumer
Affairs Council agreed on 2 June not to press ahead with proposals
to implement a mandatory centralised marketing authorisation scheme
for all medicines.
One of Pfizer Global R&D's major research facilities, based in
Nerviano, Italy, has signed an expanded agreement with PerkinElmer
in which the latter will provide repair, maintenance and validation
services for sophisticated...
A science and technology advisory group has called on the Irish
government to ensure that the country remains competitive in the
pharmaceutical and chemical industries by developing R&D
operations and, in particular, fostering...
The European Commission has published a draft monograph in the
European Pharmacopoeia for BASF's recently-introduced
sustained-release coating polymer Kollicoat SR 30 D and a modified
monograph for Kollicoat MAE 30 DP.
UK firm Cobra Bio-Manufacturing has announced its intention to
undertake a placing and open offer to raise £4.65 million (€6.45m)
to fund the purchase of an additional manufacturing plant in
The European Federation of Pharmaceutical Industries and
Associations has called for the European Commission to set up a
more favourable legal framework to help the region's pharmaceutical
industry compete with its peers in the...
UK company SkyePharma is expecting to achieve turnover of £100
million (€139m) in 2003, which would represent a rise of around 40
per cent over last year. However, the company has warned that the
lion's share of this total would...
Reports in Ireland have suggested that Germany's Schwarz Pharma is
planning to scale back its operations in Shannon and cut its
workforce. The company is allegedly planning to reduce its Irish
workforce by 70 to around 180 staff.
US biopharmaceutical firm Acceptys has licensed an immortal
humanised cell line from Columbia University, which will allow it
to discover and produce fully human monoclonal antibodies and other
human proteins for use as therapeutic...
Speciality chemical company Rohm and Haas has created a new
business unit, Advanced Biosciences, that specialises in the
production and purification of biopharmaceuticals. The new unit is
well placed to address the shortfall in production...
The European Commission has given the go-ahead for Germany to grant
a proposed €78 million in aid to help Merck KGaA build a new
biopharmaceuticals plant for the production of oncology products in
Schering-Plough has extended its relationship with enterprise
content management specialist Documentum by taking out a
non-exclusive license to GXPharma, a product jointly developed by
Documentum and IBM.
Switzerland's Solvias AG, a specialist in scientific and technical
services and products based on synthesis and analysis, has reported
a healthy 20 per cent hike in 2002 sales to SF43.6 million
(€28.6m). The increase was driven...
US pharmaceutical major Eli Lilly has earmarked a hefty £220
million (€304 million) investment over the next four years in its
UK facilities, representing the largest investment by the firm in
any European country.
US pharmaceutical major Pfizer reinforced its position as the
world's largest drug company in 2002 after putting in sales of
$29.45 billion (€25.12 bn) in 2002, a hike of 11 per cent over the
prior year, according to a new analysis...
The German state of Saxony has implemented a $230 million,
five-year investment programme in a bid to nurture the development
of 'biosaxony,' centring on the establishment of regional
biotechnology hot spots in Leipzig and...
Baxter Healthcare and GlycoFi have entered into a two-year research
collaboration under which Baxter will evaluate the potential of
using the latter firm's fungal expression platform for the
production of human therapeutic proteins....
Belgian pharmaceutical and chemicals firm Solvay expects to launch
a new version of its Influvac brand flu vaccine, based on a novel
cell-based production process, in 2005. The speed of the new
process means that a vaccine can be...
Aventis has licensed in a new system from US firm SciQuest aimed at
enhancing the management of biological sample inventories at its
process development facilities in Frankfurt, Germany and
Vitry-sur-Seine in France. If this initial...
Drug delivery company Atrix Laboratories confirmed this week that
the German regulatory authority, Bundesinstitut fur Arzneimittel
und Medizinprodukte (BfArM), had recently completed a successful
inspection of Atrix's manufacturing...
BASF AG's Fine Chemicals division is expanding production of
pharmaceutical active ingredients with the construction of a new
plant at its site in Minden, Germany. A spokesman for the company
told In-pharmatechnologist.com that...
As this edition of In-pharmatechnologist.com goes online, the US
Food and Drug Administration is convening the inaugural meeting of
its Advisory Committee for Pharmaceutical Science's Manufacturing
"Tremendous advances in science and technology, along with the
shrinking period for patent exclusivity, are creating unprecedented
opportunities for the drug development industry," said a CEO
this week while discussing the...
An international conference serving global centres of excellence
for biotechnology, so-called 'bio-technopoles,' life science parks
and 'bio-incubators' will take place ahead of the 7th European